VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Strong Trading Volume – Here’s What Happened

VanEck Pharmaceutical ETF (NASDAQ:PPH) shares saw unusually-strong trading volume on Thursday . Approximately 505,316 shares were traded during trading, an increase of 171% from the previous session’s volume of 186,442 shares.The stock last traded at $91.65 and had previously closed at $91.50.

VanEck Pharmaceutical ETF Price Performance

The firm’s 50-day moving average is $89.48 and its 200 day moving average is $91.26. The stock has a market cap of $573.14 million, a price-to-earnings ratio of 30.55 and a beta of 0.72.

VanEck Pharmaceutical ETF Increases Dividend

The company also recently announced a dividend, which was paid on Monday, December 30th. Investors of record on Friday, December 27th were issued a $0.411 dividend. The ex-dividend date was Friday, December 27th. This is a boost from VanEck Pharmaceutical ETF’s previous dividend of $0.36.

Hedge Funds Weigh In On VanEck Pharmaceutical ETF

Several hedge funds and other institutional investors have recently made changes to their positions in the business. SBI Securities Co. Ltd. acquired a new position in VanEck Pharmaceutical ETF during the 4th quarter worth approximately $29,000. Activest Wealth Management acquired a new position in shares of VanEck Pharmaceutical ETF during the fourth quarter worth $32,000. Park Square Financial Group LLC acquired a new position in shares of VanEck Pharmaceutical ETF during the fourth quarter worth $43,000. Tidemark LLC boosted its stake in shares of VanEck Pharmaceutical ETF by 123.6% in the fourth quarter. Tidemark LLC now owns 1,183 shares of the company’s stock valued at $102,000 after purchasing an additional 654 shares during the period. Finally, FMR LLC grew its holdings in VanEck Pharmaceutical ETF by 12.5% during the 3rd quarter. FMR LLC now owns 1,905 shares of the company’s stock valued at $181,000 after purchasing an additional 212 shares in the last quarter.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.